In 2021, Susan was elected to the Board of Directors of the American Association for Cancer Research. In addition to her role at AstraZeneca, Susan serves on the Scientific Advisory Board of the ICR and on the European Association of Cancer Research Advisory Council. In 2017, she was awarded an honorary Doctorate of Medical Science from the Institute of Cancer Research (ICR), and in 2018 was admitted to the Fellowship of the Academy of Medical Sciences. In 1997, Susan gained a Fellowship of the Royal College of Radiologists and completed a PhD at the University of London involving translational work on a vascular-targeting molecule. She trained in medicine at Manchester and Cambridge Universities, was admitted to the Royal College of Physicians in 1992, and then trained in clinical oncology in London. Susan has over 20 years of experience in drug discovery and development with a background as a clinical oncologist. I look forward to continuing to work with the outstanding team here at AstraZeneca and our partners to advance our plans and achieve great outcomes for patients and our company.” This ambition drives our bold strategy and pulls us together as a team so that we can realise the potential of our Oncology medicines, accelerate the delivery of the next wave of science, and make an even bigger difference to patients around the world. Susan Galbraith, Executive Vice President, Oncology R&D, said: “I am honoured to take on this position as we continue our work to one day cure cancer. Susan’s experience, energy, and passion for investing in the next generation of scientists will be invaluable to AstraZeneca’s next chapter of growth.”ĭr. She is also an exceptional leader who, together with her high-performing team, will continue to rapidly advance our exciting Oncology pipeline and execute the strategy that Susan helped to devise with José Baselga. Over the past decade at AstraZeneca, she has developed new medicines that have transformed care and improved the lives of patients around the world. Pascal Soriot, CEO, said: “Susan is an outstanding oncologist with a track record of delivering breakthrough science. Partnerships, alliances and recognition.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |